-

Dr. Korch to Retire as NBACC Lab Director

COLUMBUS, Ohio--(BUSINESS WIRE)--Today Dr. George W. Korch announced his retirement at the end of September, 2022 as Director of the National Biodefense Analysis and Countermeasures Center (NBACC) and President of the Battelle National Biodefense Institute (BNBI).

“Since December 2018, Dr. Korch has overseen the expansion and enhancement of multiple programs at NBACC through critical periods of transition and during the uncertainties of the COVID-19 pandemic response,” said Dr. Mark Peters, Battelle Executive Vice President for National Laboratory Management and Operations.

During his tenure, NBACC personnel and program achieved national recognition for their timely and important studies regarding the SARS CoV-2 virus’ biological response and viability.

Dr. Korch’s principal focus was on the advancement of his fellow workers at BNBI and the safe operations of this unique and critical facility.

“I leave behind a highly talented, dedicated workforce which has served to always achieve mission success for our Federal sponsors at the Department of Homeland Security and the Federal Bureau of Investigation,” said Dr. Korch.

Dr. Korch has served in a variety of leadership positions over his nearly 40-year tenure as a U.S. Army officer, and as a senior leader in the offices of the Assistant Secretary for Preparedness and Response, Department of Health and Human Services.

Dr. Nicholas Bergman will take over as acting BNBI President and NBACC Laboratory Director, while BNBI conducts a comprehensive and inclusive national search for its next President and Lab Director.

NBACC, a Federally Funded Research and Development Center, is operated and managed by BNBI for the DHS Science and Technology Directorate. NBACC is located on Fort Detrick in Frederick, Maryland.

Contacts

Katy Delaney
(614) 424-7208
delaneyk@battelle.org

T.R. Massey
(614) 424-5544
masseytr@battelle.org

Battelle Logo
Battelle Logo

Battelle


Release Versions

Contacts

Katy Delaney
(614) 424-7208
delaneyk@battelle.org

T.R. Massey
(614) 424-5544
masseytr@battelle.org

More News From Battelle

Battelle Extends Longstanding CDC Partnership with New Public Health Data and Mission Support Awards

COLUMBUS, Ohio--(BUSINESS WIRE)--Battelle today announced two significant awards from the Centers for Disease Control and Prevention (CDC), reinforcing the organization's longstanding partnership in advancing public health through data, analytics, science, and mission support services. Battelle was awarded a five-year, $12.3 million contract to provide information systems and technical data support for CDC's National Environmental Public Health (NEPH) Tracking Network, a critical resource that...

Battelle, CMC Pharmaceuticals Advance Medical Countermeasure Program for U.S. Department of War

COLUMBUS, Ohio--(BUSINESS WIRE)--Battelle and CMC Pharmaceuticals are advancing work with the United States Department of War to develop improved medical countermeasures intended to protect American warfighters from nerve agent threats. The five-year, $40 million Acetylcholinesterase (AChE) Reactivator Development and Approval Pipeline (ARDAP) Prototype Program was awarded through the Defense Threat Reduction Agency, Joint Science and Technology Office (DTRA-JSTO). The program is focused on adv...

Battelle Awarded Contract to Enhance Airbase Resilience

COLUMBUS, Ohio--(BUSINESS WIRE)--Battelle has been awarded a Defense Technical Information Center (DTIC) Information Analysis Center Multiple Award Contract (IAC MAC) Research, Development, Test and Evaluation (RDT&E) contract. The work will cover Operational Airbase Infrastructure Emerging Capabilities and Prototyping for the U.S. Air Force Civil Engineer Center (AFCEC) Capability Requirements Branch (CXAR). The award includes a $51.6 million base period, with a total potential value of $1...
Back to Newsroom